Saving Babies' Lives Project Impact & Results Evaluation: a Mixed

Status Completed

Clinical Trial Summary

The study is a multicentre evaluation of maternity care delivered through the Saving Babies' Lives care bundle using both quantitative and qualitative methodologies. The study will be conducted in twenty NHS Hospital Trusts from six NHS Strategic Clinical Networks totalling approximately 100,000 births. It involves participation by both service users and care providers.

To determine the impact of the care bundle on pregnancy outcomes, birth data and other clinical measures will be extracted from maternity databases and case-note audit from before and after implementation. Additionally, this study will employ questionnaires with organisational leads and review clinical guidelines to assess how resources, leadership and governance may affect implementation in diverse hospital settings. The cost of implementing the care bundle, and the cost per stillbirth avoided, will also be estimated as part of a health economic analysis. The views and experiences of service users and service providers towards maternity care in relation to the care bundle will be also be sought using questionnaires.

This study will provide practice-based evidence to advance knowledge about the processes that underpin successful implementation of the care bundle so that it can be further developed and refined. This has the potential to translate into substantial improvements in the rate of late stillbirth in the UK should the care bundle be proved effective.

Clinical Trial Description

Reducing stillbirth and early neonatal death is a national priority. Best practice and key evidence indicates this is potentially achievable through application of four key interventions within routine maternity care delivered as NHS England's Saving Babies' Lives care bundle. However, adoption of the care bundle by UK maternity services is still in its infancy and there is significant variation in the degree of implementation between and within units. The effectiveness of the care bundle, when implemented as a package, in reducing stillbirth and service delivery has not yet been evaluated. This study aims to evaluate the impact of implementing the care bundle on UK maternity services and perinatal outcomes. ;

Study Design

Related Conditions & MeSH terms

Stillbirth

Clinical Trial Details

NCT number	NCT03231007
Study type	Observational
Source	University of Manchester
Contact
Status	Completed
Phase
Start date	July 10, 2017
Completion date	July 5, 2018

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03605511` - TTP and aHUS in Complicated Pregnancies
Completed	`NCT02379728` - Ghana PrenaBelt Trial: A Positional Therapy Device to Reduce Still-Birth	N/A
Not yet recruiting	`NCT01664546` - Study of the Best Blastocyst Post Transfer by aCGH	N/A
Completed	`NCT02218931` - ESTEEM - Effect of Simple, Targeted Diet in Pregnant Women With Metabolic Risk Factors on Pregnancy Outcomes	N/A
Recruiting	`NCT03662178` - Investigating the Structured Use of Ultrasound Scanning for Fetal Growth
Completed	`NCT03290924` - Accelerating Newborn Survival in Ghana Through a Low-dose, High-frequency Health Worker Training Approach	N/A
Recruiting	`NCT05901688` - Umbilical Cord Abnormalities in the Prediction of Adverse Pregnancy Outcomes
Completed	`NCT02339077` - Group B Streptococcus (GBS) Associated Stillbirths in a High Burden Setting
Completed	`NCT03112018` - Strengthening Facility-based Intrapartum/Immediate Newborn Care to Reduce Mortality of Preterm Infants in Migori County, Kenya and Busoga Region, Uganda	N/A
Completed	`NCT02862925` - Introducing Fetal Scalp Stimulation as an Adjunct to Intermittent Auscultation in Low-Resource Settings.	N/A
Completed	`NCT02318420` - The PartoMa Project: For Improving Monitoring, Action and Triage During Labour	N/A
Recruiting	`NCT05757167` - Improving Neonatal Health Through Rapid Malaria Testing in Early Pregnancy With High-Sensitivity Diagnostics	Phase 4
Completed	`NCT02148952` - BetterBirth: A Trial of the WHO Safe Childbirth Checklist Program	N/A
Active, not recruiting	`NCT01995968` - Antenatal Detection of Fetal Growth Restriction and Stillbirths Rate.	N/A
Completed	`NCT00270530` - Intermittent Preventive Treatment of Malaria in HIV-Seropositive Pregnant Women in Zambia	Phase 4
Completed	`NCT04600076` - MOMSonLINE2 ; A Pilot Study Testing Recruitment and Retention of Women of Color to an Online Support Group for Bereaved Mothers	N/A
Completed	`NCT03363308` - Effects of a Health Workforce Capacity Building and Quality Improvement Intervention in Kinshasa	N/A
Completed	`NCT03722615` - Epidemiology of Congenital Cytomegalovirus in a High HIV Prevalence Setting, South Africa
Completed	`NCT02907242` - Revealed Versus Concealed Cerebroplacental Ratio	N/A
Recruiting	`NCT02336243` - A Randomized Trial of Docosahexaenoic Acid Supplementation During Pregnancy to Prevent Deep Placentation Disorders	Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Saving Babies' Lives Project Impact and Results Evaluation: a Mixed Methodology Study — SPiRE

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms